skip to primary navigationskip to content
 

Group Leaders

 

Mike Murphy

Dr Mike Murphy

MRC-Mitochondrial Biology Unit, University of Cambridge

The Murphy lab is developing mitochonria-specific therapeutic molecules and probes, with a focus on preventing and assessing pathological oxidative damage. Within the MTG, the lab focuses on  the role of mitochondrial oxidative damage and the efficacy of potential therapies in collaboration with the other labs.                                                                                    

email: mpm@mrc-mbu.cam.ac.uk

http://www.mrc-mbu.cam.ac.uk/people/mike-murphy 

 

Dr Richard Hartley

Dr Richard C. Hartley

WestCHEM School of Chemistry, University of Glasgow

Dr Hartley is a professor of chemical biology with a research focus on developing small molecule probes for elucidating biological processes both on a cellular and a whole organism level. His laboratory focuses on specific targeting of therapeutics to mitochondria through these small molecule probes.                                                

email: Richard.Hartley@glasgow.ac.uk

http://www.chem.gla.ac.uk/staff/richh/Site/Research.html

Mr Kourosh Saeb-Parsy

Mr Kourosh Saeb-Parsy

Department of Surgery, University of Cambridge

Kourosh Saeb-Parsy is a University Lecturer and Consultant Transplant Surgeon; his collaborative research programme within the MTG uses a range of in vivo and ex vivo models of transplant ischaemia reperfusion to understand the underlying mechanisms, its impact on short-term and long-term transplant graft outcomes and its therapeutic amelioration.                                                                                     

email:

http://www.fitz.cam.ac.uk/content/dr-kourosh-saeb-parsy  

Dr Christian Frezza

Dr Christian Frezza

MRC Cancer Unit, University of Cambridge

Dr. Frezza's work focuses on metabolomics and the detection, identification and quantitation of the small molecule metabolites present in biofluids, tissues, and cells. His lab focuses on elucidating the connection between mitochondria, mitochondrial enzymes, and cancer.

email:                                                                                                                          http://www.mrc-cu.cam.ac.uk/frezza.html

Dr Thomas Krieg

Dr Thomas Krieg

Department of Medicine, University of Cambridge

Dr Krieg is a Lecturer in Clinical Pharmacology with a research focus directed toward identifying therapies that prevent cell death in ischemic heart. He focuses in identifying complex signal transduction pathways involved in cell death due to ischaemia. 

email:tk382@medschl.cam.ac.uk

http://emit.medschl.cam.ac.uk/people/investigators/dr-thomas-krieg/